February 20, 2008
Senator Sam Brownback to Speak at Global Health Partnering Forum
The Biotechnology Industry Organization (BIO) and BIO Ventures for Global Health (BVGH) are pleased to announce U.S. Senator Sam Brownback, R-Kan., will deliver the Breakfast Plenary, “Incentives to Drive Innovation,” at the Partnering for Global Health Forum 2008, to be held March 11-12 near Washington, D.C.
January 24, 2008
Partnering for Global Health Forum 2008 to Create a New Paradigm for Addressing Most Pressing Global Health Issues
The Biotechnology Industry Organization (BIO) and BIO Ventures for Global Health (BVGH) are pleased to announce that Anthony Fauci, MD, of NIH’s National Institute of Allergy and Infectious Diseases will be delivering a roundtable on global health from bench to bedside, and Cheryl Scott of the Bill & Melinda Gates Foundation will be delivering a fireside chat on global health issues at the Partnering for Global Health Forum, co-sponsored by the Gates Foundation.
May 8 , 2007
BVGH and BIO Launch Initiative to Engage Biotech Companies in Global Health R&D
BIO Ventures for Global Health (BVGH) and the Biotechnology Industry Organization (BIO) today unveiled plans to co-host the
Partnering for Global Health Forum 2008.
February 9, 2007
BIO Ventures for Global Health Commends the Launch of First Advance Market Commitment
BIO Ventures for Global Health (BVGH) commends today’s launch of the first Advance Market Commitment (AMC), a novel financing mechanism to encourage industry investment in much-needed vaccines for the developing world.
October 20, 2006
BIO Ventures for Global Health Study Identifies Significant Market for Tuberculosis Vaccines
According to a groundbreaking study released today by BIO Ventures for Global Health (BVGH), a vaccine to prevent tuberculosis presents a significant opportunity for industry investment with a potential global market of US $450 million to nearly $1 billion.
May 24, 2006
BIO Ventures for Global Health Announces Appointment of Julie Klim as Vice President of Business Development
BIO Ventures for Global Health (BVGH) announced the appointment today of Julie Klim, previously Co-Founder and Principal at Capital Royalty L.P., as Vice President of Business Development.
October 3, 2005
BIO Ventures for Global Health Announces Appointment of Christopher Earl As New CEO
BIO Ventures for Global Health (BVGH) today announced that Christopher D. Earl, PhD, a leading venture capitalist and entrepreneur in the biotechnology industry, has been appointed president, chief executive officer and director of BVGH. Dr. Earl was previously managing director at the Perseus-Soros BioPharmaceutical Fund.
June 21, 2005
BIO Ventures for Global Health Announces Bill & Melinda Gates Foundation Grant to Expand Biotech Industry’s Role in Fight Against Neglected Diseases
BIO Ventures for Global Health today announced it will expand its efforts to enlist biotechnology companies in the fight to improve global health, with a new $5.4 million grant from the Bill & Melinda Gates Foundation. The announcement was made at BIO 2005, the biotech industry’s annual convention.
June
7,
2004
BIO
Launches BIO Ventures for Global Health With Initial Grant from
Bill & Melinda Gates Foundation
The Biotechnology
Industry Organization (BIO) today announced the launch
of BIO Ventures for Global Health (BVGH), a new nonprofit
organization that will work to enlist the biotechnology
industry in the fight against neglected diseases. BVGH
has received a $1 million start-up grant from the Bill & Melinda
Gates Foundation...
May
3, 2004
Biotech's
Role in Improving Global Health
The biotechnology
industry is working to overcome hurdles to provide patients
in the developing world with the significant medicines
it has created to battle such devastating diseases as AIDS,
malaria and tuberculosis. BIO 2004, the Biotechnology Industry
Organization's
(BIO's) Annual International Convention, which
will take place June 6-9 at San Francisco's Moscone
Center, will feature...
